ALDEYRA THERAPEUTICS INC (ALDX)
US01438T1060 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -44.80M | -37.54M | -62.02M | -57.78M | -37.55M | |||
| Depreciation Amortization | 248.03K | 262.78K | 260.00K | 260.00K | 60.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | 0.00 | -480.00K | |||
| Change In Working Capital | 8.97M | 861.18K | -3.44M | 7.44M | -8.83M | |||
| Interest Paid | 1.77M | 1.70M | 1.34M | 1.34M | 1.39M | |||
| Other non cash items | 4.91M | 6.09M | 8.57M | 7.52M | 9.31M | |||
| OPERATING CASH FLOW | -30.67M | -30.33M | -56.64M | -42.56M | -37.49M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -20.00K | -10.00K | 0.00 | |||
| Other Investing Activity | -43.35M | 30.00M | -29.94M | 0.00 | 29.02M | |||
| INVESTING CASH FLOW | -43.35M | 30.00M | -29.95M | -10.00K | 29.02M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -1.04M | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | N/A | 194.13K | 1.12M | 194.43M | 41.78M | |||
| Other Financing Activity | 36.21K | -421.85K | 100.00K | 60.00K | 130.00K | |||
| FINANCING CASH FLOW | -1.19M | -1.27M | 1.22M | 194.50M | 41.90M | |||
| CHANGE IN CASH | -75.21M | -1.60M | -85.37M | 151.93M | 33.43M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -30.67M | -30.33M | -56.64M | -42.56M | -37.49M | |||
| Capital Expenditure | N/A | 0.00 | -20.00K | -10.00K | 0.00 | |||
| FREE CASH FLOW | -30.67M | -30.33M | -56.66M | -42.57M | -37.49M | |||
All data in USD